Company profile for Antares Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Antares Pharma is a specialty pharmaceutical company that combines drug development expertise with proprietary delivery technology to deliver safe and effective medicines. With a goal of improving dosing, reducing side effects, and improving patient compliance and outcomes, our pursuit of innovative therapies strives to positively affect patients’ lives. We focus on self-injection, pharmaceutical products and technologies w...
Antares Pharma is a specialty pharmaceutical company that combines drug development expertise with proprietary delivery technology to deliver safe and effective medicines. With a goal of improving dosing, reducing side effects, and improving patient compliance and outcomes, our pursuit of innovative therapies strives to positively affect patients’ lives. We focus on self-injection, pharmaceutical products and technologies with emphasis in rheumatology, urology, endocrinology, and neurology. Through innovation, Antares Pharma combines pharmaceutical and medical device knowledge to produce treatment options.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
100 Princeton South Suite 300 Ewing, New Jersey 08628
Telephone
Telephone
(609) 359-3020
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/drug-delivery/jj-roche-partner-halozyme-buys-antares-pharma-1b-beefing-drug-delivery-offerings

A. Liu FIERCEPHARMA
14 Apr 2022

https://www.globenewswire.com/news-release/2022/03/29/2411744/35385/en/Antares-Pharma-Announces-FDA-Approval-Of-TLANDO-an-Oral-Treatment-for-Testosterone-Replacement-Therapy.html

GLOBENEWSWIRE
29 Mar 2022

https://www.globenewswire.com/news-release/2022/03/03/2396099/35385/en/Antares-Pharma-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-and-Operating-Results.html

GLOBENEWSWIRE
03 Mar 2022

https://www.globenewswire.com/news-release/2022/02/28/2393191/35385/en/Antares-Pharma-to-Present-at-the-Cowen-42nd-Annual-Healthcare-Conference.html

GLOBENEWSWIRE
28 Feb 2022

https://www.globenewswire.com/news-release/2022/02/03/2378482/35385/en/Antares-Pharma-Announces-FDA-Acceptance-of-NDA-Resubmission-for-TLANDO.html

GLOBENEWSWIRE
03 Feb 2022

https://www.prnewswire.com/news-releases/lipocine-announces-its-partner-received-fda-acceptance-of-nda-resubmission-for-tlando-301474456.html

PRNEWSWIRE
03 Feb 2022

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty